This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Société ADWYA Valuation

Is ADWYA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ADWYA?

Other financial metrics that can be useful for relative valuation.

ADWYA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.7x
Enterprise Value/EBITDA13.7x
PEG Ratio3.8x

Price to Sales Ratio vs Peers

How does ADWYA's PS Ratio compare to its peers?

The above table shows the PS ratio for ADWYA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average1.5x
UMED Unité de Fabrication des Médicaments
2.2x8.0%د.ت248.0m
SPL Starpharma Holdings
13.2xn/aAU$53.4m
541096 Bharat Parenterals
1.3xn/a₹3.6b
APPH Apontis Pharma
0.7x15.1%€32.1m
ADWYA Société ADWYA
1.2x7.0%د.ت128.1m

Price-To-Sales vs Peers: ADWYA is good value based on its Price-To-Sales Ratio (1.2x) compared to the peer average (1.5x).


Price to Earnings Ratio vs Industry

How does ADWYA's PE Ratio compare vs other companies in the African Pharmaceuticals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a17.1%
n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a17.1%
n/an/an/a
No more companies

Price-To-Sales vs Industry: ADWYA is expensive based on its Price-To-Sales Ratio (1.2x) compared to the African Pharmaceuticals industry average (0.9x)


Price to Sales Ratio vs Fair Ratio

What is ADWYA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ADWYA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.2x
Fair PS Ratio1.5x

Price-To-Sales vs Fair Ratio: ADWYA is good value based on its Price-To-Sales Ratio (1.2x) compared to the estimated Fair Price-To-Sales Ratio (1.5x).


Share Price vs Fair Value

What is the Fair Price of ADWYA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ADWYA (TND5.95) is trading above our estimate of fair value (TND0.61)

Significantly Below Fair Value: ADWYA is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies